FDA Warns Doctors of Abbott Trifecta Valve Deterioration Risks
The FDA warns that Abbott Trifecta heart valve implants may deteriorate within only a few years, leading to the need for valve replacement and increasing the risk of patient death.
The FDA warns that Abbott Trifecta heart valve implants may deteriorate within only a few years, leading to the need for valve replacement and increasing the risk of patient death.
The FDA warns that MitraClip heart valve repair devices may malfunction, resulting in a backflow of blood into the heart.
Implanting pacemakers into recent heart valve replacement patients may increase their risk of death, according to the findings of a new study.
A new study warns that giving Plavix and aspirin to heart valve replacement patients may increase their risk of bleeding events.
The FDA has issued a draft guidance on how to determine what medical devices can enter an MRI machine safely.
Some bioprosthetic heart valves are not opening and closing normally, raising concerns within the FDA, which is trying to develop new studies to see if the reduced motion is a…